Reproducibility of the peritoneal regression grading score for assessment of response to therapy in peritoneal metastasis.

Solass, W, Sempoux, C, Carr, N J, Bibeau, F, Neureiter, D, Jager, T, Di Caterino, T, Brunel, C, Klieser, E, Fristrup, C W, Mortensen, M B, Detlefsen, S.

Histopathology, (2019) 74 (7):1014-24.doi:10.1111/his.13829 PMID:30687944

Systemic inflammatory response after hyperthermic intraperitoneal chemotherapy (HIPEC): The perfusion protocol matters!

Roth, L, Eshmuminov, D, Laminger, F, Koppitsch, C, Schneider, M, Graf, T R, Gupta, A, Kober, F, Roka, S, Gertsch, P, Lehmann, K.

Eur J Surg Oncol, (2019) doi: 10.1016/j.ejso.2019.03.036 PMID:30954352

Long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal metastases of urachal cancer.

Mertens, L S, Behrendt, M A, Mehta, A M, Stokkel, L, de Jong, J, Boot, H, Horenblas, S, van der Heijden, M S, Moonen, L M, Aalbers, A G J, Meinhardt, W, van Rhijn, B W G.

Eur J Surg Oncol, (2019) doi: 10.1016/j.ejso.2019.03.034 PMID:31003721

RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score.

Arjona-Sanchez, A, Rodriguez-Ortiz, L, Baratti, D, Schneider, M A, Gutierrez-Calvo, A, Garcia-Fadrique, A, Tuynman, J B, Cascales-Campos, P A, Martin, V C, Morales, R, Salti, G I, Arteaga, X, Pacheco, D, Alonso-Gomez, J, Yalkin, O, Villarejo-Campos, P, Sanchez-Hidalgo, J M, Casado-Adam, A, Cosano-Alvarez, A, Rufian-Pena, S, Briceno, J.

Ann Surg Oncol, (2019) doi: 10.1245/s10434-019-07378-9 PMID:31111351

Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (Abraxane) for peritoneal carcinomatosis – a phase I first-in-human study.

Van De Sande, L, Graversen, M, Hubner, M, Pocard, M, Reymond, M, Vaira, M, Cosyns, S, Willaert, W, Ceelen, W.

Pleura Peritoneum, (2018) 3 (2):20180112.doi:10.1515/pp-2018-0112 PMID:30911657

Inflammatory Response and Toxicity After Pressurized IntraPeritoneal Aerosol Chemotherapy.

Teixeira Farinha, H, Grass, F, Labgaa, I, Pache, B, Demartines, N, Hubner, M.

J Cancer, (2018) 9 (1):13-20.doi:10.7150/jca.21460 PMID:29290765

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with standard of care chemotherapy in primarily untreated chemo naive upper gi-adenocarcinomas with peritoneal seeding – a phase II/III trial of the AIO/CAOGI/ACO.

Oliver Goetze, T, Al-Batran, S E, Pabst, U, Reymond, M, Tempfer, C, Bechstein, W O, Bankstahl, U, Gockel, I, Konigsrainer, A, Kraus, T, Monig, S P, Rau, B, Schwarzbach, M, Piso, P.

Pleura Peritoneum, (2018) 3 (2):20180113.doi: 10.1515/pp-2018-0113 PMID:30911658

http://www.ncbi.nlm.nih.gov/pubmed/30911658

The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the “Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR)”, the Swiss and Austrian AGO, and the North-Eastern German Society of Gynaecologic Oncology.

Dueckelmann, A M, Fink, D, Harter, P, Heinzelmann, V, Marth, C, Mueller, M, Reinthaller, A, Tamussino, K, Wimberger, P, Sehouli, J.

Arch Gynecol Obstet, (2018) 297 (4):837-46.doi:10.1007/s00404-018-4673-0 PMID:29356953

The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI).

Bushati, M, Rovers, K P, Sommariva, A, Sugarbaker, P H, Morris, D L, Yonemura, Y, Quadros, C A, Somashekhar, S P, Ceelen, W, Dube, P, Li, Y, Verwaal, V J, Glehen, O, Piso, P, Spiliotis, J, Teo, M C C, Gonzalez-Moreno, S, Cashin, P H, Lehmann, K, Deraco, M, Moran, B, de Hingh, I.

Eur J Surg Oncol, (2018) 44 (12):1942-8.doi:10.1016/j.ejso.2018.07.003 PMID:30075978

Impact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study.

Teixeira Farinha, H, Grass, F, Kefleyesus, A, Achtari, C, Romain, B, Montemurro, M, Demartines, N, Hubner, M.

Gastroenterol Res Pract, (2017) 2017:4596176.doi 10.1155/2017/4596176 PMID:28316621

Major postoperative complications are a risk factor for impaired survival after CRS/HIPEC.

Schneider, M A, Eshmuminov, D, Lehmann, K.

Ann Surg Oncol, (2017) doi: 10.1245/s10434-017-5821-7 PMID:28265776

Feasibility and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis: A Retrospective Cohort Study.

Hubner, M, Teixeira Farinha, H, Grass, F, Wolfer, A, Mathevet, P, Hahnloser, D, Demartines, N.

Gastroenterol Res Pract, (2017) 2017:6852749.doi:10.1155/2017/6852749 PMID:28331493

Pressurized IntraPeritoneal Aerosol Chemotherapy – Practical aspects.

Hubner, M, Grass, F, Teixeira-Farinha, H, Pache, B, Mathevet, P, Demartines, N.

Eur J Surg Oncol, (2017) 43 (6):1102-9.doi: 10.1016/j.ejso.2017.03.019 PMID:28431896

http://www.ncbi.nlm.nih.gov/pubmed/28431896

Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis.

Grass, F, Vuagniaux, A, Teixeira-Farinha, H, Lehmann, K, Demartines, N, Hubner, M.

Br J Surg, (2017) 104 (6):669-78.doi:10.1002/bjs.10521 PMID:28407227

Intraperitoneal chemotherapy and cytoreductive surgery for peritoneal metastases coupled with curative treatment of colorectal liver metastases: an updated systematic review.

El-Nakeep, S, Rashad, N, Oweira, H, Schmidt, J, Helbling, D, Giryes, A, Petrausch, U, Mehrabi, A, Decker, M, Abdel-Rahman, O.

Expert Rev Gastroenterol Hepatol, (2017) 11 (3):249-58.doi:10.1080/17474124.2017.1284586 PMID:28099818